In this context, and given the known tumoral heterogeneity in this disease [20], we aimed to compare the expression of c-Met between paired primary and metastatic sites in clear-cell RCC (ccRCC) tissues. The gene discussed is MET; the disease is nonpapillary renal cell carcinoma.